A rating of 52 puts Cortexyme Inc (CRTX) near the middle of the Biotechnology industry according to InvestorsObserver. Cortexyme Inc's score of 52 means it scores higher than 52% of stocks in the industry. Cortexyme Inc also received an overall rating of 40, putting it above 40% of all stocks. Biotechnology is ranked 93 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 40 means the stock is more attractive than 40 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Cortexyme Inc Stock Today?
Cortexyme Inc (CRTX) stock is trading at $34.67 as of 2:18 PM on Tuesday, Apr 13, a gain of $2.79, or 8.74% from the previous closing price of $31.88. The stock has traded between $31.88 and $35.27 so far today. Volume today is less active than usual. So far 154,212 shares have traded compared to average volume of 304,991 shares.
Click Here to get the full Stock Score Report on Cortexyme Inc (CRTX) Stock.
